Enhanced killing of antibiotic-resistant bacteria enabled by massively parallel combinatorial genetics

被引:28
作者
Cheng, Allen A. [1 ,2 ,3 ,6 ,7 ]
Ding, Huiming [4 ]
Lu, Timothy K. [1 ,2 ,5 ,6 ]
机构
[1] MIT, MIT Synthet Biol Ctr, Dept Elect Engn & Comp Sci, Elect Res Lab,Synthet Biol Grp, Cambridge, MA 02139 USA
[2] MIT, MIT Synthet Biol Ctr, Dept Biol Engn, Elect Res Lab,Synthet Biol Grp, Cambridge, MA 02139 USA
[3] MIT, Harvard MIT Hlth Sci & Technol, Med Engn & Med Phys Program, Cambridge, MA 02139 USA
[4] MIT, MIT BioMicro Ctr, Dept Biol Engn, Cambridge, MA 02139 USA
[5] MIT, MIT Microbiol Program, Cambridge, MA 02139 USA
[6] Harvard Univ, Harvard Biophys Program, Boston, MA 02115 USA
[7] Harvard Univ, Harvard MD PhD Program, Boston, MA 02115 USA
基金
美国国家卫生研究院;
关键词
synthetic biology; combination therapy; systems biology; drug resistance; multifactorial genetics; MISSING HERITABILITY; ESCHERICHIA-COLI; TRANSCRIPTION FACTORS; IDENTIFICATION; CEFTRIAXONE; EXPRESSION; CELLS; RNAI;
D O I
10.1073/pnas.1400093111
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
New therapeutic strategies are needed to treat infections caused by drug-resistant bacteria, which constitute a major growing threat to human health. Here, we use a high-throughput technology to identify combinatorial genetic perturbations that can enhance the killing of drug-resistant bacteria with antibiotic treatment. This strategy, Combinatorial Genetics En Masse (Com-biGEM), enables the rapid generation of high-order barcoded combinations of genetic elements for high-throughput multiplexed characterization based on next-generation sequencing. We created similar to 34,000 pairwise combinations of Escherichia coli transcription factor (TF) overexpression constructs. Using Illumina sequencing, we identified diverse perturbations in antibiotic-resistance phenotypes against carbapenem-resistant Enterobacteriaceae. Specifically, we found multiple TF combinations that potentiated antibiotic killing by up to 10(6)-fold and delivered these combinations via phagemids to increase the killing of highly drug-resistant E. coli harboring New Delhi metallo-beta-lactamase-1. Moreover, we constructed libraries of three-wise combinations of transcription factors with >4 million unique members and demonstrated that these could be tracked via next-generation sequencing. We envision that CombiGEM could be extended to other model organisms, disease models, and phenotypes, where it could accelerate massively parallel combinatorial genetics studies for a broad range of biomedical and biotechnology applications, including the treatment of antibiotic-resistant infections.
引用
收藏
页码:12462 / 12467
页数:6
相关论文
共 57 条
[1]   Combinatorial drug therapy for cancer in the post-genomic era [J].
Al-Lazikani, Bissan ;
Banerji, Udai ;
Workman, Paul .
NATURE BIOTECHNOLOGY, 2012, 30 (07) :679-691
[2]  
[Anonymous], 2000, GENOME RES, DOI DOI 10.1101/gr.143000
[3]   ROTATING ANTIBIOTICS SELECTS OPTIMALLY AGAINST ANTIBIOTIC RESISTANCE, IN THEORY [J].
Beardmore, Robert E. ;
Pena-Miller, Rafael .
MATHEMATICAL BIOSCIENCES AND ENGINEERING, 2010, 7 (03) :527-552
[4]   Inhibition of transcription factors with small organic molecules [J].
Berg, Thorsten .
CURRENT OPINION IN CHEMICAL BIOLOGY, 2008, 12 (04) :464-471
[5]   eSGA:: E. coli synthetic genetic array analysis [J].
Butland, Gareth ;
Babu, Mohan ;
Diaz-Mejia, J. Javier ;
Bohdana, Fedyshyn ;
Phanse, Sadhna ;
Gold, Barbara ;
Yang, Wenhong ;
Li, Joyce ;
Gagarinova, Alla G. ;
Pogoutse, Oxana ;
Mori, Hirotada ;
Wanner, Barry L. ;
Lo, Henry ;
Wasniewski, Jas ;
Christopoulos, Constantine ;
Ali, Mehrab ;
Venn, Pascal ;
Safavi-Naini, Anahita ;
Sourour, Natalie ;
Caron, Simone ;
Choi, Ja-Yeon ;
Laigle, Ludovic ;
Nazarians-Armavil, Anaies ;
Deshpande, Avnish ;
Joe, Sarah ;
Datsenko, Kirill A. ;
Yamamoto, Natsuko ;
Andrews, Brenda J. ;
Boone, Charles ;
Ding, Huiming ;
Sheikh, Bilal ;
Moreno-Hagelsieb, Gabriel ;
Greenblatt, Jack F. ;
Emili, Andrew .
NATURE METHODS, 2008, 5 (09) :789-795
[6]  
Centers for Disease Control and Prevention, 2013, Antibiotic Resistance Threats in the United States, 2013
[7]   Harnessing synthetic lethal interactions in anticancer drug discovery [J].
Chan, Denise A. ;
Giaccia, Amato J. .
NATURE REVIEWS DRUG DISCOVERY, 2011, 10 (05) :351-364
[8]   Lessons from Nature: microRNA-based shRNA libraries [J].
Chang, Kenneth ;
Elledge, Stephen J. ;
Hannon, Gregory J. .
NATURE METHODS, 2006, 3 (09) :707-714
[9]   REVIEW OF PIPERACILLIN TAZOBACTAM IN THE TREATMENT OF BACTEREMIC INFECTIONS AND SUMMARY OF CLINICAL EFFICACY [J].
CHARBONNEAU, P .
INTENSIVE CARE MEDICINE, 1994, 20 :S43-S48
[10]   Inhibition of mutation and combating the evolution of antibiotic resistance [J].
Cirz, RT ;
Chin, JK ;
Andes, DR ;
de Crécy-Lagard, V ;
Craig, WA ;
Romesberg, FE .
PLOS BIOLOGY, 2005, 3 (06) :1024-1033